These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists. Madonna R; Cocco N; De Caterina R Cardiovasc Drugs Ther; 2015; 29(5):469-79. PubMed ID: 26145170 [TBL] [Abstract][Full Text] [Related]
23. Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Hansmann G; Apitz C Heart; 2016 May; 102 Suppl 2():ii67-85. PubMed ID: 27053700 [TBL] [Abstract][Full Text] [Related]
29. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study. Hay BR; Pugh ME; Robbins IM; Hemnes AR Chest; 2016 Mar; 149(3):660-6. PubMed ID: 26378379 [TBL] [Abstract][Full Text] [Related]
30. Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside. Mazzola M; Madonna R; Badagliacca R; Caterina R Vascul Pharmacol; 2022 Aug; 145():107022. PubMed ID: 35738494 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary arterial hypertension specific therapy: The old and the new. Zolty R Pharmacol Ther; 2020 Oct; 214():107576. PubMed ID: 32417272 [TBL] [Abstract][Full Text] [Related]
32. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483 [No Abstract] [Full Text] [Related]